
    
      To characterize pharmacokinetic profile of Imatinib Mesylate tablets EQ 400 mg base of Amneal
      Pharmaceuticals LLC, compared to that of the reference product - GLEEVECÂ® (imatinib mesylate)
      tablets 400 mg in adult patients, who are diagnosed to have CML or GIST and are presently
      receiving stable dose of imatinib mesylate tablets 400 mg, and assess their bioequivalence.
    
  